# Bone Biologics Corp: Form 10-Q for the period ended Sep 30, 2022

- Company: [Bone Biologics Corp](/companies/bblg.md) (CIK 1419554)
- Form: 10-Q
- Filed: 2022-11-14
- Accepted by EDGAR: Nov 14, 2022, 06:32 ET
- Period: 2022-09-30
- Accession: 0001493152-22-031540
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1419554/000149315222031540/form10-q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1419554/000149315222031540/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2022-07-01 to 2022-09-30 | $769.4k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2022-01-01 to 2022-09-30 | $823.4k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2022-07-01 to 2022-09-30 | −$1.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2022-01-01 to 2022-09-30 | −$2.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 9 months, 2022-01-01 to 2022-09-30 | $1.6k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-07-01 to 2022-09-30 | −$1.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2022-01-01 to 2022-09-30 | −$2.4m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months, 2022-07-01 to 2022-09-30 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2022-01-01 to 2022-09-30 | −$0.23 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months, 2022-01-01 to 2022-09-30 | −$1.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2022-09-30 | $5.1m | us-gaap:Cash |
| Total assets | at 2022-09-30 | $5.2m | us-gaap:Assets |
| Total liabilities | at 2022-09-30 | $799.5k | us-gaap:Liabilities |
| Shareholders' equity | at 2022-09-30 | $4.4m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1419554/000149315222031540/form10-q.htm

Filed Nov 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-031540. Last ingested by Listed: Nov 11, 2026, 03:46 ET. No prices; not investment advice.
